Metabolic diseases including obesity, type 2 diabetes and cardiovascular disease are strongly associated with reduced insulin receptor function on target cells, often concomitant with elevated blood insulin levels, referred to as a state of insulin resistance (Lee and Olefsky, 2021). Here, INS is linked to metabolic disease.